Cardiovascular risk in patients with rheumatoid arthritis
Authors:
Kristína Brázdilová 1; Roman Gál 2; Zdenko Killinger 1; Juraj Payer 1
Authors place of work:
V. interná klinika LF UK a UNB, Nemocnica Ružinov, Bratislava
1; Interné oddelenie NsP Brezno
2
Published in the journal:
AtheroRev 2018; 3(2): 106-108
Category:
Reviews
Summary
Rheumatoid arthritis is a chronic inflammatory disease which, in addition to joint, may also have extraarticular manifestations. At present, we know that patients with rheumatoid arthritis have an increased risk of cardiovascular disease, which is even comparable to that of patients with diabetes mellitus. The application of preventive measures as well as the awareness of professionals and patients themselves on increased cardiovascular risk, are one of the most important factors that can ultimately affect morbidity and mortality while improving quality of life.
Key words:
cardiovascular risk, rheumatoid arthritis
Zdroje
- Gabriel SE. Cardiovascular morbidity and mortality in rheumatoid arthritis. Am J Med 2008; 121(10 Suppl 1): S9-S14. Dostupné z DOI: <http://dx.doi.org/10.1016/j.amjmed.2008.06.011>.
- Voskuyl AE. The heart and cardiovascular manifestations in rheumatoid arthritis. Rheumatology (Oxford) 2006; 45(Suppl 4): :iv4-iv7. Dostupné z DOI: <http://dx.doi.org/10.1093/rheumatology/kel313>.
- Das S, Padhan P. An overview of the extraarticular involvement in rheumatoid arthritis and its management. J Pharmacol Pharmacother 2017; 8(3): 81–86. Dostupné z DOI: <http://dx.doi.org/10.4103/jpp.JPP_194_16>.
- Chung CP, Oeser A, Raggi P et al. Increased coronary artery atherosclerosis in rheumatoid arthritis: relationship to disease duration and cardiovascular risk factors. Arthritis Rheum 2005; 52(10): 3045–3053. Dostupné z DOI: <http://dx.doi.org/10.1002/art.21288>.
- Braun J, Kruger K, Manger B et al. Cardiovascular comorbidity in inflammatory rheumatological conditions. Dtsch Arztebl Int 2017; 114(12): 197–203. Dostupné z DOI: <http://dx.doi.org/10.3238/arztebl.2017.0197>.
- del Rincon I, Freeman GL, Haas RW et al. Relative contribution of cardiovascular risk factors and rheumatoid arthritis clinical manifestations to atherosclerosis. Arthritis Rheum 2005; 52(11): 3413–3423. Dostupné z DOI: <http://dx.doi.org/10.1002/art.21397>.
- Agca R, Heslinga SC, Rollefstad S et al. EULAR recommendations for cardiovascular disease risk management in patients with rheumatoid arthritis and other forms of inflammatory joint disorders: 2015/2016 update. Ann Rheum Dis 2017; 76(1): 17–28. Dostupné z DOI: <http://dx.doi.org/10.1136/annrheumdis-2016–209775>.
- Liang KP, Liang KV, Matteson EL et al. Incidence of noncardiac vascular disease in rheumatoid arthritis and relationship to extraarticular disease manifestations. Arthritis Rheum 2006; 54(2): 642–648. Dostupné z DOI: <http://dx.doi.org/10.1002/art.21628>.
- Meune C, Touzé E, Trinquart L et al. Trends in cardiovascular mortality in patients with rheumatoid arthritis over 50 years: a systematic review and meta-analysis of cohort studies. Rheumatology (Oxford) 2009; 48(10): 1309–1313. Dostupné z DOI: <http://dx.doi.org/10.1093/rheumatology/kep252>.
- Wagan AA, Haider SN, Ahmed R et al. Modifiable cardiovascular risk factors in rheumatoid arthritis. Pak J Med Sci 2017; 33(4): 973–978. Dostupné z DOI: <http://dx.doi.org/10.12669/pjms.334.12798>.
- Sur G, Sur M, Kudor-Szabadi L et al. Arterial hypertension – prevalence of risk factors and morbide associations that increase cardiovascular risk. Maedica (Buchar) 2010; 5(1): 34–40.
- Ivanovic B, Tadic M. Hypercholesterolemia and hypertension: two sides of the same coin. Am J Cardiovasc Drugs 2015; 15(6): 403–414. Dostupné z DOI: <http://dx.doi.org/10.1007/s40256–015–0128–1>.
Štítky
Angiology Diabetology Internal medicine Cardiology General practitioner for adultsČlánok vyšiel v časopise
Athero Review
2018 Číslo 2
- Memantine Eases Daily Life for Patients and Caregivers
- Metamizole vs. Tramadol in Postoperative Analgesia
- Metamizole at a Glance and in Practice – Effective Non-Opioid Analgesic for All Ages
- Advances in the Treatment of Myasthenia Gravis on the Horizon
- Spasmolytic Effect of Metamizole
Najčítanejšie v tomto čísle
- What a rheumatologist should know about statins and their side effects
- Familial chylomicronemia: pathogenesis, clinical manifestations and case study
- Detection of aortic calcifications within the assessment of lateral densitometric scans
- The impact of rheumatic diseases on cardiovascular risk and lipidogram